L
Lexicon Pharmaceuticals
Biopharmaceutical company that has harnessed the power of genetics for drug discovery
At a glance
- Status
- Listed
- Founded
- 1995
- Headquarters
- The Woodlands, United States
- Listing
- IPO 1998
- Sector
- Biotech & Life Sciences
- Outcome tier
- Thoroughbred$100M+ revenue
Knowledge graph
News
More headlines
Open roles
Lexicon Pharmaceuticals in the The Woodlands ecosystem
The Lexicon Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
NEA- BMBaylor College of Medicine
Source: Dealroom Talent Intelligence.
Alumni founders
Former Lexicon Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
Pablo LapuertaUnited States
PEPetMedixEst. 2017
Allan BradleyUnited KingdomGlobal footprint
team presence
across markets
Patents
73 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lexicon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lexicon Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

